- ►physiology.org IF Benter, MHM Yousif, C Cojocel, M Al- … - American Journal of …, 2007 - Am Physiological Soc The aim of this study was to test the hypothesis that treatment with angiotensin-(1–7)
[ANG-(1–7)] or ANG-(1–7) nonpeptide analog AVE-0991 can produce protection against
diabetes-induced cardiovascular dysfunction. We examined the influence of chronic ... Cited by 20 - Related articles - BL Direct - All 5 versions
A Martinuzzi, A Liava, E Trevisi, M Frare, C … - Muscle and …, 2008 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 10 - Related articles - BL Direct - All 4 versions
- ►asnjournals.org P Ruggenenti, P Bettinaglio, F Pinares, G … - Clinical Journal of the …, 2008 - Am Soc Nephrol Despite the huge amount of studies looking for candidate genes, the ACE gene remains the
unique, well-characterized locus clearly associated with pathogenesis and progression of chronic
kidney disease, and with response to treatment with drugs that directly interfere with the ... Cited by 9 - Related articles - All 4 versions
- ►bentham.org [PDF] T Lely, PT Luik, G Navis - Current Diabetes Reviews, 2007 - ingentaconnect.com Abstract: The renin-angiotensin aldosterone system (RAAS) is well-established to be involved
in diabetic nephropathy. Several abnormalities in the RAAS have been described in diabetes
mellitus, including an abnormal aldosterone to renin ratio, elevated angiotensin ... Cited by 1 - Related articles - BL Direct - All 5 versions
ION RENAL - dissertations.ub.rug.nl Page 1. ANGIOTENSIN CONVERTING ENZYME AND ITS IMPACT ON RENAL DISEASE P art
2 Page 2. 94 Page 3. ANGIOTENSIN I- CONVERTING ENZYME: A PATHOGENETIC ROLE IN
DIABETIC RENAL DAMAGE? Titia Lely Peter Luik Gerjan Navis Chapter 6 Page 4. ... Related articles - View as HTML - All 2 versions
B Volkan-Salanci, S Dagdelen, M Alikasifoglu, … - Journal of Renin- …, 2009 - jra.sagepub.com Journal of the Renin- Angiotensin- Aldosterone System (Including other Peptidergic
systems) ... * Department of Nuclear Medicine, Faculty of Medicine, Hacettepe University,
Ankara, Turkey. ... † Division of Endocrinology and Metabolism, Department of Internal ... Related articles - All 5 versions
M Rudnicki, G Mayer - Pharmacogenomics, 2009 - Future Medicine The angiotensin converting enzyme (ACE) is a component of the renin–angiotensin–aldosterone
system (RAAS). The RAAS – involved primarily in blood pressure and sodium homeostasis –
is activated in many renal and cardiovascular diseases, and therapy with ACE inhibitors ... Cited by 1 - Related articles - All 4 versions
BH Rovin, AM McKinley, DJ Birmingham - Clinical Journal of the …, 2009 - Am Soc Nephrol The idea of individualizing therapies to obtain optimal clinical results is not new but has only
recently been applied to kidney diseases. Nonetheless, kidney disorders present a variety of
opportunities to personalize medicine. Here, the heterogeneity of kidney disorders is ... Related articles - All 3 versions